Additionally, their activity in ESR1-mutant clones makes them especially relevant for women with atypical hyperplasia or lobular carcinoma in situ (LCIS), who may harbor occult genomic alterations [81]. This evidence concerns the gene ESR1 and lobular breast carcinoma in situ.